Anagrelide
Overview
Anagrelide is a drug used for the treatment of essential thrombocytosis, or overproduction of blood platelets. It also has been used in the treatment of chronic myeloid leukemia. Anagrelide controlled release is in phase III clinical trials by Galena Biopharma for the treatment of essential thrombocytosis
Anant Labs manufacture and furnish high quality Anagrelide impurities for global markets. Our Anagrelide EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS—
Mol. FormulaC10H7Cl2N3O
Mol. Weight256.092 g/mol
IUPAC6,7-dichloro-5,10-dihydro-3H-imidazo[2,1-b]quinazolin-2-one
SMILESC1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3
InChIInChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)
InChI KeyOTBXOEAOVRKTNQ-UHFFFAOYSA-N
Note: We are upgrading our system, Cat No will change.






